BSRR Sierra Banc beats earnings estimates by 14 percent yet shares decline 178 percent despite EPS outperformance Is Cap Clean CCEC stock misaligned with fundamentals Cap Clean posts 272 EPS beat vs analyst targets Is institutional money buying TScan Therapeutics TCRX stock Q4 2025 Profit Exceeds Views AMRZ Amrize shares decline as Q1 earnings miss estimates by 54 raising concerns about profitability path